Clearance deficiency and cell death pathways: A model for the pathogenesis of SLE

Frontiers in Immunology

Volumn 7, Issue FEB, 2016, Pages

  Mahajan, Aparna ^a   Herrmann, Martin ^a   Muñoz, Luis E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Autoantibody; Clearance; NETosis; SLE

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; AUTOANTIGEN; C REACTIVE PROTEIN; CELL NUCLEUS ANTIGEN; FC RECEPTOR; FRACTALKINE; GROWTH ARREST SPECIFIC PROTEIN 6; HERMES ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTADHERIN; LYSOPHOSPHATIDYLCHOLINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTROPHIL CYTOPLASMIC ANTIBODY; OPSONIN; PENTRAXIN 3; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; AUTOIMMUNITY; CELL DIFFERENTIATION; CLEARANCE; CYTOKINE RELEASE; EXTRACELLULAR TRAP; FOLLICULAR DENDRITIC CELL; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; MACROPHAGE ACTIVATION; NEUTROPHIL CHEMOTAXIS; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE NECROSIS;

EID: 84962577206     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00035     Document Type: Review

References (134)

1. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2012) 19(1):107-20. doi: 10.1038/cdd.2011.96.
2. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 26(4):239-57. doi:10.1038/bjc.1972.33.
3. Biermann M, Maueroder C, Brauner JM, Chaurio R, Janko C, Herrmann M, et al. Surface code-biophysical signals for apoptotic cell clearance. Phys Biol (2013) 10(6):065007. doi:10.1088/1478-3975/10/6/065007.
4. Zirngibl M, Furnrohr BG, Janko C, Munoz LE, Voll RE, Gregory CD, et al. Loading of nuclear autoantigens prototypically recognized by SLE sera into late apoptotic vesicles requires intact microtubules and MLCK activity. Clin Exp Immunol (2015) 179(1):39-49. doi:10.1111/cei.12342.
5. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 35(4):495-516. doi:10.1080/01926230701320337.
6. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature (1997) 390(6658):350-1. doi:10.1038/37022.
7. Stach CM, Turnay X, Voll RE, Kern PM, Kolowos W, Beyer TD, et al. Treatment with annexin V increases immunogenicity of apoptotic human T-cells in Balb/c mice. Cell Death Differ (2000) 7(10):911-5. doi:10.1038/sj.cdd.4400715.
8. Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M. Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev (2005) 4(4):189-94. doi:10.1016/j.autrev.2004.10.007.
9. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 9(5):353-63. doi:10.1038/nri2545.
10. Vénéreau E, Ceriotti C, Bianchi ME. DAMPs from death to new life. Front Immunol (2015) 6:422. doi:10.3389/fimmu.2015.00422.
11. Maueroder C, Chaurio R, Dumych T, Podolska M, Lootsik M, Culemann S, et al. A blast without power-cell death induced by the Tuberculosis-Necrotizing Toxin (TNT) fails to elicit adequate immune responses. Cell Death Differ (2016). doi:10.1038/cdd.2016.4.
12. Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol (2012) 198(5):773-83. doi:10.1083/jcb.201203170.
13. Akong-Moore K, Chow OA, von Kockritz-Blickwede M, Nizet V. Influences of chloride and hypochlorite on neutrophil extracellular trap formation. PLoS One (2012) 7(8):e42984. doi:10.1371/journal.pone.0042984.
14. Guimaraes-Costa AB, Nascimento MT, Wardini AB, Pinto-da-Silva LH, Saraiva EM. ETosis: a microbicidal mechanism beyond cell death. J Parasitol Res (2012) 2012:929743. doi:10.1155/2012/929743.
15. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol (2007) 7(12):964-74. doi:10.1038/nri2214.
16. Weichand B, Weis N, Weigert A, Grossmann N, Levkau B, Brune B. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration. Eur J Immunol (2013) 43(12):3306-13. doi:10.1002/eji.201343441.
17. Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell (2003) 113(6):717-30. doi:10.1016/S0092-8674(03)00422-7.
18. Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, et al. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood (2008) 112(13):5026-36. doi:10.1182/blood-2008-06-162404.
19. Peter C, Wesselborg S, Herrmann M, Lauber K. Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells. Apoptosis (2010) 15(9):1007-28. doi:10.1007/s10495-010-0472-1.
20. Bournazou I, Pound JD, Duffin R, Bournazos S, Melville LA, Brown SB, et al. Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J Clin Invest (2009) 119(1):20-32. doi:10.1172/JCI36226.
21. Appelt U, Sheriff A, Gaipl US, Kalden JR, Voll RE, Herrmann M. Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ (2005) 12(2):194-6. doi:10.1038/sj.cdd.4401527.
22. Janko C, Jeremic I, Biermann M, Chaurio R, Schorn C, Munoz LE, et al. Cooperative binding of Annexin A5 to phosphatidylserine on apoptotic cell membranes. Phys Biol (2013) 10(6):065006. doi:10.1088/1478-3975/10/6/065006.
23. Chaurio RA, Janko C, Munoz LE, Frey B, Herrmann M, Gaipl US. Phospholipids: key players in apoptosis and immune regulation. Molecules (2009) 14(12):4892-914. doi:10.3390/molecules14124892.
24. Biermann MH, Veissi S, Maueroder C, Chaurio R, Berens C, Herrmann M, et al. The role of dead cell clearance in the etiology and pathogenesis of systemic lupus erythematosus: dendritic cells as potential targets. Expert Rev Clin Immunol (2014) 10(9):1151-64. doi:10.1586/1744666X.2014.944162.
25. Kinchen JM, Ravichandran KS. Journey to the grave: signaling events regulating removal of apoptotic cells. J Cell Sci (2007) 120(Pt 13):2143-9. doi:10.1242/jcs.03463.
26. Fairn GD, Grinstein S. How nascent phagosomes mature to become phagolysosomes. Trends Immunol (2012) 33(8):397-405. doi:10.1016/j.it.2012.03.003.
27. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 6(5):280-9. doi:10.1038/nrrheum.2010.46.
28. Svensson BO. Serum factors causing impaired macrophage function in systemic lupus erythematosus. Scand J Immunol (1975) 4(2):145-50.
29. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum (1998) 41(7):1241-50. doi:10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H.
30. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun (2007) 28(2-3):114-21. doi:10.1016/j.jaut.2007.02.005.
31. Munoz LE, Frey B, Appelt U, Janko C, Sarter K, Voll R, et al. Peripheral blood stem cells of patients with systemic lupus erythematosus show altered differentiation into macrophages. Open Autoimmun J (2010) 2:11-6. doi:10.2174/1876894601002010011.
32. Munoz LE, Chaurio RA, Gaipl US, Schett G, Kern P. MoMa from patients with systemic lupus erythematosus show altered adhesive activity. Autoimmunity (2009) 42(4):269-71. doi:10.1080/08916930902827983.
33. Cairns AP, Crockard AD, McConnell JR, Courtney PA, Bell AL. Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Ann Rheum Dis (2001) 60(10):950-5. doi:10.1136/ard.60.10.950.
34. Smith JP, Burton GF, Tew JG, Szakal AK. Tingible body macrophages in regulation of germinal center reactions. Dev Immunol (1998) 6(3-4):285-94. doi:10.1155/1998/38923.
35. Winkler TH, Fehr H, Kalden JR. Analysis of immunoglobulin variable region genes from human IgG anti-DNA hybridomas. Eur J Immunol (1992) 22(7):1719-28. doi:10.1002/eji.1830220709.
36. Wellmann U, Letz M, Herrmann M, Angermuller S, Kalden JR, Winkler TH. The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A (2005) 102(26):9258-63. doi:10.1073/pnas.0500132102.
37. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum (2002) 46(1):191-201. doi:10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K.
38. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med (2000) 192(11):1545-52. doi:10.1084/jem.192.11.1545.
39. Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med (2000) 192(11):1553-62. doi:10.1084/jem.192.11.1553.
40. Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med (1995) 181(4):1557-61. doi:10.1084/jem.181.4.1557.
41. Manfredi AA, Rovere P, Galati G, Heltai S, Bozzolo E, Soldini L, et al. Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. Arthritis Rheum (1998) 41(2):205-14. doi:10.1002/1529-0131(199802)41:2<215::AID-ART5>3.0.CO;2-X.
42. Song-Chou Hseih C-LY. Autoantibody profiling in systemic lupus erythematosus. Curr Biomark Find (2013) 3:55-65. doi:10.2147/CBF.S34496.
43. Rovere P, Sabbadini MG, Vallinoto C, Fascio U, Recigno M, Crosti M, et al. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies. Arthritis Rheum (1999) 42(7):1412-20. doi:10.1002/1529-0131(199907)42:7<1412::AID-ANR15>3.0.CO;2-T.
44. Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, et al. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 30(1):104-16. doi:10.1016/0090-1229(84)90011-4.
45. Alba P, Bento L, Cuadrado MJ, Karim Y, Tungekar MF, Abbs I, et al. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis (2003) 62(6):556-60. doi:10.1136/ard.62.6.556.
46. Diamond B, Volpe BT. A model for lupus brain disease. Immunol Rev (2012) 248(1):56-67. doi:10.1111/j.1600-065X.2012.01137.x.
47. Sun XY, Shi J, Han L, Su Y, Li ZG. Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J Clin Lab Anal (2008) 22(4):271-7. doi:10.1002/jcla.20248.
48. Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol (2011) 40(1):27-41. doi:10.1007/s12016-009-8190-6.
49. Provost TT, Reichlin M. Antinuclear antibody-negative systemic lupus erythematosus. I. Anti-Ro(SSA) and anti-La(SSB) antibodies. J Am Acad Dermatol (1981) 4(1):84-9. doi:10.1016/S0190-9622(81)70013-6.
50. Ghirardello A, Doria A, Ruffatti A, Rigoli AM, Vesco P, Calligaro A, et al. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ann Rheum Dis (1994) 53(2):140-2. doi:10.1136/ard.53.2.140.
51. Sun KH, Liu WT, Tsai CY, Liao TS, Lin WM, Yu CL. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis (1992) 51(6):707-12. doi:10.1136/ard.51.6.707.
52. Tsai CY, Yu CL, Wu TH, Lu JY, Lair TS, Tsai YY, et al. Polyclonal anticardiolipin antibodies purified from sera of patients with active systemic lupus erythematosus induce apoptosis of the cultured glomerular mesangial cells. Scand J Rheumatol (2000) 29(6):370-9. doi:10.1080/030097400447570.
53. Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci (2009) 1173:47-51. doi:10.1111/j.1749-6632.2009.04746.x.
54. Carmona-Rivera C, Kaplan MJ. Detection of SLE antigens in neutrophil extracellular traps (NETs). Methods Mol Biol (2014) 1134:151-61. doi:10.1007/978-1-4939-0326-9_11.
55. Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol (2000) 27(1):109-15.
56. Mansour RB, Lassoued S, Gargouri B, El Gaid A, Attia H, Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol (2008) 37(2):103-8. doi:10.1080/03009740701772465.
57. Al-Shobaili HA, Al Robaee AA, Alzolibani AA, Rasheed Z. Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index. Immunol Invest (2013) 42(3):191-203. doi:10.3109/08820139.2012.751396.
58. Kienhofer D, Hahn J, Schubert I, Reinwald C, Ipseiz N, Lang SC, et al. No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis. PLoS One (2014) 9(12):e115474. doi:10.1371/journal.pone.0115474.
59. Zhao MH, Liu N, Zhang YK, Wang HY. Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis. Nephrol Dial Transplant (1998) 13(11):2821-4. doi:10.1093/ndt/13.11.2821.
60. Manolova I, Dancheva M, Halacheva K. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int (2001) 20(5):197-204. doi:10.1007/s002960100108.
61. Novo E, Garcia-MacGregor E, Viera N, Chaparro N, Crozzoli Y. Periodontitis and anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus and rheumatoid arthritis: a comparative study. J Periodontol (1999) 70(2):185-8. doi:10.1902/jop.1999.70.2.185.
62. Caccavo D, Rigon A, Picardi A, Galluzzo S, Vadacca M, Ferri GM, et al. Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates. Clin Rheumatol (2005) 24(4):381-7. doi:10.1007/s10067-004-1040-2.
63. Pradhan VD, Badakere SS, Bichile LS, Almeida AF. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Phys India (2004) 52:533-7.
64. Mannik M, Merrill CE, Wener MH. Antibodies to human myeloperoxidase in glomerular immune deposits of systemic lupus erythematosus. Lupus (2000) 9(8):607-13. doi:10.1191/096120300678828758.
65. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med (1994) 180(6):2341-6. doi:10.1084/jem.180.6.2341.
66. Zhuang H, Han S, Xu Y, Li Y, Wang H, Yang LJ, et al. Toll-like receptor 7-stimulated tumor necrosis factor alpha causes bone marrow damage in systemic lupus erythematosus. Arthritis Rheumatol (2014) 66(1):140-51. doi:10.1002/art.38189.
67. Urbonaviciute V, Starke C, Pirschel W, Pohle S, Frey S, Daniel C, et al. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus. Arthritis Rheum (2013) 65(6):1612-23. doi:10.1002/art.37914.
68. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8(5):487-96. doi:10.1038/ni1457.
69. Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ. Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol (2007) 18(6):1721-31. doi:10.1681/ASN.2006101162.
70. Chen J, Carey K, Godowski PJ. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene (1997) 14(17):2033-9. doi:10.1038/sj.onc.1201039.
71. Lauber K, Keppeler H, Munoz LE, Koppe U, Schroder K, Yamaguchi H, et al. Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death Differ (2013) 20(9):1230-40. doi:10.1038/cdd.2013.82.
72. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med (2002) 196(1):135-40. doi:10.1084/jem.20012094.
73. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science (2004) 304(5674):1147-50. doi:10.1126/science.1094359.
74. Seredkina N, Rekvig OP. Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis. Am J Pathol (2011) 179(3):1120-8. doi:10.1016/j.ajpath.2011.05.011.
75. Yoshida H, Okabe Y, Kawane K, Fukuyama H, Nagata S. Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nat Immunol (2005) 6(1):49-56. doi:10.1038/ni1146.
76. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature (2006) 443(7114):998-1002. doi:10.1038/nature05245.
77. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci U S A (2010) 107(21):9813-8. doi:10.1073/pnas.0909927107.
78. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis (1999) 58(5):309-14. doi:10.1136/ard.58.5.309.
79. Ma CY, Jiao YL, Zhang J, Yang QR, Zhang ZF, Shen YJ, et al. Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-alpha and TNF-alpha in systemic lupus erythematosus. Rheumatol Int (2012) 32(2):395-402. doi:10.1007/s00296-010-1636-6.
80. Vordenbaumen S, Fischer-Betz R, Timm D, Sander O, Chehab G, Richter J, et al. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus. Lupus (2010) 19(14):1648-53. doi:10.1177/0961203310377089.
81. Nassberger L. Distribution of antineutrophil cytoplasmic autoantibodies in SLE patients with and without renal involvement. Am J Nephrol (1996) 16(6):548-9. doi:10.1159/000169058.
82. Fauzi AR, Kong NC, Chua MK, Jeyabalan V, Idris MN, Azizah R. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med J Malaysia (2004) 59(3):372-7.
83. Molnar K, Kovacs L, Kiss M, Husz S, Dobozy A, Pokorny G. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Clin Exp Dermatol (2002) 27(1):59-61. doi:10.1046/j.0307-6938.2001.00964.x.
84. Tamiya H, Tani K, Miyata J, Sato K, Urata T, Lkhagvaa B, et al. Defensins-and cathepsin G-ANCA in systemic lupus erythematosus. Rheumatol Int (2006) 27(2):147-52. doi:10.1007/s00296-006-0173-9.
85. Mohammad AJ, Weiner M, Sjowall C, Johansson ME, Bengtsson AA, Stahl-Hallengren C, et al. Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden. Nephrol Dial Transplant (2015) 30(Suppl 1):i23-30. doi:10.1093/ndt/gfu396.
86. Pan HF, Fang XH, Wu GC, Li WX, Zhao XF, Li XP, et al. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis. Inflammation (2008) 31(4):260-5. doi:10.1007/s10753-008-9073-3.
87. Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum (1986) 29(11):1334-42. doi:10.1002/art.1780291105.
88. Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol (2010) 184(6):3284-97. doi:10.4049/jimmunol.0902199.
89. Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, et al. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum (2009) 60(6):1733-42. doi:10.1002/art.24535.
90. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med (2013) 5(178):178ra40. doi:10.1126/scitranslmed.3005580.
91. Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I, et al. Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout. PLoS One (2011) 6(12):e29318. doi:10.1371/journal.pone.0029318.
92. Pieterse E, van der Vlag J. Breaking immunological tolerance in systemic lupus erythematosus. Front Immunol (2014) 5:164. doi:10.3389/fimmu.2014.00164.
93. Niewold TB, Clark DN, Salloum R, Poole BD. Interferon alpha in systemic lupus erythematosus. J Biomed Biotechnol (2010) 2010:948364. doi:10.1155/2010/948364.
94. Lindau D, Mussard J, Rabsteyn A, Ribon M, Kotter I, Igney A, et al. TLR9 independent interferon alpha production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen. Ann Rheum Dis (2014) 73(12):2199-207. doi:10.1136/annrheumdis-2012-203041.
95. Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. J Immunol (2013) 191(5):2647-56. doi:10.4049/jimmunol.1300436.
96. Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE, et al. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum (2004) 50(2):640-9. doi:10.1002/art.20034.
97. Yeh TM, Chang HC, Liang CC, Wu JJ, Liu MF. Deoxyribonuclease-inhibitory antibodies in systemic lupus erythematosus. J Biomed Sci (2003) 10(5):544-51. doi:10.1007/BF02256116.
98. Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol (2012) 188(7):3522-31. doi:10.4049/jimmunol.1102404.
99. Schorn C, Janko C, Krenn V, Zhao Y, Munoz LE, Schett G, et al. Bonding the foe-NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals. Front Immunol (2012) 3:376. doi:10.3389/fimmu.2012.00376.
100. Quartier P, Potter PK, Ehrenstein MR, Walport MJ, Botto M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur J Immunol (2005) 35(1):252-60. doi:10.1002/eji.200425497.
101. Munoz LE, Janko C, Schulze C, Schorn C, Sarter K, Schett G, et al. Autoimmunity and chronic inflammation-two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev (2010) 10(1):38-42. doi:10.1016/j.autrev.2010.08.015.
102. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Ann Rev Immunology (2004) 22:431-56. doi:10.1146/annurev.immunol.22.012703.104549.
103. Gaipl US, Franz S, Voll RE, Sheriff A, Kalden JR, Herrmann M. Defects in the disposal of dying cells lead to autoimmunity. Curr Rheumatol Rep (2004) 6(6):401-7. doi:10.1007/s11926-004-0016-1.
104. Roberts JL, Schwartz MM, Lewis EJ. Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis. Clin Exp Immunol (1978) 31(2):328-38.
105. Meyer O, Hauptmann G, Tappeiner G, Ochs HD, Mascart-Lemone F. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin Exp Immunol (1985) 62(3):678-84.
106. Chen Z, Koralov SB, Kelsoe G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med (2000) 192(9):1339-52. doi:10.1084/jem.192.9.1339.
107. Mattecka S, Bock C, Vogt B, Yapici G, Schrodl W, Janko C, et al. CRP and SAP from different species have different membrane ligand specificities. Autoimmunity (2013) 46(5):347-50. doi:10.3109/08916934.2013.780601.
108. Du Clos TW, Zlock LT, Rubin RL. Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol (1988) 141(12):4266-70.
109. Jewell WS, Marnell LL, Rokeach LA, Du Clos TW. C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region. Mol Immunol (1993) 30(8):701-8. doi:10.1016/0161-5890(93)90141-W.
110. Janko C, Franz S, Munoz LE, Siebig S, Winkler S, Schett G, et al. CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immunol (2011) 2:70. doi:10.3389/fimmu.2011.00070.
111. Janko C, Schorn C, Weidner D, Sarter K, Chaurio R, Sheriff A, et al. Treatment with DNAse I fosters binding to nec PBMC of CRP. Autoimmunity (2009) 42(4):286-8. doi:10.1080/08916930902828197.
112. Russell AI, Cunninghame Graham DS, Shepherd C, Roberton CA, Whittaker J, Meeks J, et al. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet (2004) 13(1):137-47. doi:10.1093/hmg/ddh021.
113. Sjowall C, Bengtsson AA, Sturfelt G, Skogh T. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus. Arthritis Res Ther (2004) 6(2):R87-94. doi:10.1186/ar1032.
114. Enocsson H, Sjowall C, Skogh T, Eloranta ML, Ronnblom L, Wettero J. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum (2009) 60(12):3755-60. doi:10.1002/art.25042.
115. Gillmore JD, Hutchinson WL, Herbert J, Bybee A, Mitchell DA, Hasserjian RP, et al. Autoimmunity and glomerulonephritis in mice with targeted deletion of the serum amyloid P component gene: SAP deficiency or strain combination? Immunology (2004) 112(2):255-64. doi:10.1111/j.1365-2567.2004.01860.x.
116. Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, et al. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity. Ann Rheum Dis (2005) 64(12):1698-702. doi:10.1136/ard.2005.035832.
117. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 179(4):1317-30. doi:10.1084/jem.179.4.1317.
118. Sarmiento LF, Munoz LE, Chirinos P, Bianco NE, Zabaleta-Lanz ME. Opsonization by anti-dsDNA antibodies of apoptotic cells in systemic lupus erythematosus. Autoimmunity (2007) 40(4):337-9. doi:10.1080/08916930701356663.
119. Grossmayer GE, Munoz LE, Weber CK, Franz S, Voll RE, Kern PM, et al. IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Ann Rheum Dis (2008) 67(11):1626-32. doi:10.1136/ard.2007.081828.
120. Knight JS, Kaplan MJ. Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr Opin Rheumatol (2012) 24(5):441-50. doi:10.1097/BOR.0b013e3283546703.
121. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science (1999) 284(5421):1835-7. doi:10.1126/science.284.5421.1835.
122. Ronnblom L, Pascual V. The innate immune system in SLE: type I interferons and dendritic cells. Lupus (2008) 17(5):394-9. doi:10.1177/0961203308090020.
123. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science (1982) 216(4544):429-31. doi:10.1126/science.6176024.
124. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum (2004) 50(6):1861-72. doi:10.1002/art.20254.
125. Obermoser G, Pascual V. The interferon-alpha signature of systemic lupus erythematosus. Lupus (2010) 19(9):1012-9. doi:10.1177/0961203310371161.
126. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A (2003) 100(5):2610-5. doi:10.1073/pnas.0337679100.
127. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity (2006) 25(3):383-92. doi:10.1016/j.immuni.2006.08.010.
128. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med (2011) 3(73):73ra19. doi:10.1126/scitranslmed.3001180.
129. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med (2011) 3(73):73ra20. doi:10.1126/scitranslmed.3001201.
130. Manfredi AA, Covino C, Rovere-Querini P, Maugeri N. Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. Clin Exp Immunol (2015) 179(1):24-9. doi:10.1111/cei.12320.
131. Munoz LE, Herrmann M, Berens C. Dying autologous cells as instructors of the immune system. Clin Exp Immunol (2015) 179(1):1-4. doi:10.1111/cei.12478.
132. Gill JM. Diagnosis of systemic lupus erythematosus. Am Fam Physician (2003) 68(11):2179-86.
133. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol (2000) 53:424-32. doi:10.1136/jcp.53.6.424.
134. Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the tart cell and the L.E. cell. Proc Staff Meet Mayo Clin (1948) 23(2):25-8.